 | • レポートコード：QYR2104Z1073 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（臨床検査、遺伝子検査、画像診断、内視鏡検査）、用途別市場規模（膀胱がん検査、乳がん検査、子宮頸がん検査、結腸直腸（結腸）がん検査、卵巣がん検査、前立腺がん検査、肝がん検査、フローサイトメトリー、その他臓器特異的がん検査）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん検査の市場動向 ・企業の競争状況、市場シェア ・がん検査の種類別市場規模（臨床検査、遺伝子検査、画像診断、内視鏡検査） ・がん検査の用途別市場規模（膀胱がん検査、乳がん検査、子宮頸がん検査、結腸直腸（結腸）がん検査、卵巣がん検査、前立腺がん検査、肝がん検査、フローサイトメトリー、その他臓器特異的がん検査） ・がん検査の北米市場規模2016-2027（アメリカ、カナダ） ・がん検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Radient Pharmaceuticals、BD Diagnostics、Beckman Coulter、BioCurex、bioMerieux、Cepheid、CytoCore、DiagnoCure、Gen-Probe、Genomic Health、QIAGEN Marseille (Earlier Ipsogen)、Myriad Genetics、Panacea Pharmaceuticals、Qiagen、Siemens Heathcare Diagnostics、Roche、Roche(Ventana Medical Systems)、Trovagene、Vermillion） ・結論 |
Cancer is the second-leading cause of death and disability in the world, only behind heart disease. More people die from cancer around the world than AIDS, Tuberculosis and Malaria combined every year.
According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Therefore, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians.
Market Analysis and Insights: Global Cancer Test Market
The global Cancer Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Test market.
Global Cancer Test Scope and Market Size
Cancer Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Laboratory Tests
Genetic Tests
Imaging
Endoscopy
Segment by Application
Bladder Cancer Test
Breast Cancer Test
Cervical Cancer Test
Colorectal (Colon) Cancer Test
Ovarian Cancer Test
Prostate Cancer Test
Liver Cancer Test
Flow Cytometry
Other Organ Specific Cancer Test
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Radient Pharmaceuticals
BD Diagnostics
Beckman Coulter
BioCurex
bioMerieux
Cepheid
CytoCore
DiagnoCure
Beckman Coulter
BioCurex
QIAGEN Marseille (Earlier Ipsogen)
Myriad Genetics
Panacea Pharmaceuticals
Qiagen
Siemens Heathcare Diagnostics
Roche
Roche(Ventana Medical Systems)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Laboratory Tests
1.2.3 Genetic Tests
1.2.4 Imaging
1.2.5 Endoscopy
1.3 Market by Application
1.3.1 Global Cancer Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Bladder Cancer Test
1.3.3 Breast Cancer Test
1.3.4 Cervical Cancer Test
1.3.5 Colorectal (Colon) Cancer Test
1.3.6 Ovarian Cancer Test
1.3.7 Prostate Cancer Test
1.3.8 Liver Cancer Test
1.3.9 Flow Cytometry
1.3.10 Other Organ Specific Cancer Test
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Test Market Perspective (2016-2027)
2.2 Cancer Test Growth Trends by Regions
2.2.1 Cancer Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Test Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Test Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Test Industry Dynamic
2.3.1 Cancer Test Market Trends
2.3.2 Cancer Test Market Drivers
2.3.3 Cancer Test Market Challenges
2.3.4 Cancer Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Test Players by Revenue
3.1.1 Global Top Cancer Test Players by Revenue (2016-2021)
3.1.2 Global Cancer Test Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Test Revenue
3.4 Global Cancer Test Market Concentration Ratio
3.4.1 Global Cancer Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Test Revenue in 2020
3.5 Cancer Test Key Players Head office and Area Served
3.6 Key Players Cancer Test Product Solution and Service
3.7 Date of Enter into Cancer Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Test Breakdown Data by Type
4.1 Global Cancer Test Historic Market Size by Type (2016-2021)
4.2 Global Cancer Test Forecasted Market Size by Type (2022-2027)
5 Cancer Test Breakdown Data by Application
5.1 Global Cancer Test Historic Market Size by Application (2016-2021)
5.2 Global Cancer Test Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Test Market Size (2016-2027)
6.2 North America Cancer Test Market Size by Type
6.2.1 North America Cancer Test Market Size by Type (2016-2021)
6.2.2 North America Cancer Test Market Size by Type (2022-2027)
6.2.3 North America Cancer Test Market Size by Type (2016-2027)
6.3 North America Cancer Test Market Size by Application
6.3.1 North America Cancer Test Market Size by Application (2016-2021)
6.3.2 North America Cancer Test Market Size by Application (2022-2027)
6.3.3 North America Cancer Test Market Size by Application (2016-2027)
6.4 North America Cancer Test Market Size by Country
6.4.1 North America Cancer Test Market Size by Country (2016-2021)
6.4.2 North America Cancer Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Test Market Size (2016-2027)
7.2 Europe Cancer Test Market Size by Type
7.2.1 Europe Cancer Test Market Size by Type (2016-2021)
7.2.2 Europe Cancer Test Market Size by Type (2022-2027)
7.2.3 Europe Cancer Test Market Size by Type (2016-2027)
7.3 Europe Cancer Test Market Size by Application
7.3.1 Europe Cancer Test Market Size by Application (2016-2021)
7.3.2 Europe Cancer Test Market Size by Application (2022-2027)
7.3.3 Europe Cancer Test Market Size by Application (2016-2027)
7.4 Europe Cancer Test Market Size by Country
7.4.1 Europe Cancer Test Market Size by Country (2016-2021)
7.4.2 Europe Cancer Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Test Market Size (2016-2027)
8.2 Asia-Pacific Cancer Test Market Size by Type
8.2.1 Asia-Pacific Cancer Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Test Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Test Market Size by Application
8.3.1 Asia-Pacific Cancer Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Test Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Test Market Size by Region
8.4.1 Asia-Pacific Cancer Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Test Market Size (2016-2027)
9.2 Latin America Cancer Test Market Size by Type
9.2.1 Latin America Cancer Test Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Test Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Test Market Size by Type (2016-2027)
9.3 Latin America Cancer Test Market Size by Application
9.3.1 Latin America Cancer Test Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Test Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Test Market Size by Application (2016-2027)
9.4 Latin America Cancer Test Market Size by Country
9.4.1 Latin America Cancer Test Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Test Market Size (2016-2027)
10.2 Middle East & Africa Cancer Test Market Size by Type
10.2.1 Middle East & Africa Cancer Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Test Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Test Market Size by Application
10.3.1 Middle East & Africa Cancer Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Test Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Test Market Size by Country
10.4.1 Middle East & Africa Cancer Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Cancer Test Introduction
11.1.4 Abbott Revenue in Cancer Test Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Radient Pharmaceuticals
11.2.1 Radient Pharmaceuticals Company Details
11.2.2 Radient Pharmaceuticals Business Overview
11.2.3 Radient Pharmaceuticals Cancer Test Introduction
11.2.4 Radient Pharmaceuticals Revenue in Cancer Test Business (2016-2021)
11.2.5 Radient Pharmaceuticals Recent Development
11.3 BD Diagnostics
11.3.1 BD Diagnostics Company Details
11.3.2 BD Diagnostics Business Overview
11.3.3 BD Diagnostics Cancer Test Introduction
11.3.4 BD Diagnostics Revenue in Cancer Test Business (2016-2021)
11.3.5 BD Diagnostics Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Cancer Test Introduction
11.4.4 Beckman Coulter Revenue in Cancer Test Business (2016-2021)
11.4.5 Beckman Coulter Recent Development
11.5 BioCurex
11.5.1 BioCurex Company Details
11.5.2 BioCurex Business Overview
11.5.3 BioCurex Cancer Test Introduction
11.5.4 BioCurex Revenue in Cancer Test Business (2016-2021)
11.5.5 BioCurex Recent Development
11.6 bioMerieux
11.6.1 bioMerieux Company Details
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux Cancer Test Introduction
11.6.4 bioMerieux Revenue in Cancer Test Business (2016-2021)
11.6.5 bioMerieux Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Cancer Test Introduction
11.7.4 Cepheid Revenue in Cancer Test Business (2016-2021)
11.7.5 Cepheid Recent Development
11.8 CytoCore
11.8.1 CytoCore Company Details
11.8.2 CytoCore Business Overview
11.8.3 CytoCore Cancer Test Introduction
11.8.4 CytoCore Revenue in Cancer Test Business (2016-2021)
11.8.5 CytoCore Recent Development
11.9 DiagnoCure
11.9.1 DiagnoCure Company Details
11.9.2 DiagnoCure Business Overview
11.9.3 DiagnoCure Cancer Test Introduction
11.9.4 DiagnoCure Revenue in Cancer Test Business (2016-2021)
11.9.5 DiagnoCure Recent Development
11.10 Gen-Probe
11.10.1 Gen-Probe Company Details
11.10.2 Gen-Probe Business Overview
11.10.3 Gen-Probe Cancer Test Introduction
11.10.4 Gen-Probe Revenue in Cancer Test Business (2016-2021)
11.10.5 Gen-Probe Recent Development
11.11 Genomic Health
11.11.1 Genomic Health Company Details
11.11.2 Genomic Health Business Overview
11.11.3 Genomic Health Cancer Test Introduction
11.11.4 Genomic Health Revenue in Cancer Test Business (2016-2021)
11.11.5 Genomic Health Recent Development
11.12 QIAGEN Marseille (Earlier Ipsogen)
11.12.1 QIAGEN Marseille (Earlier Ipsogen) Company Details
11.12.2 QIAGEN Marseille (Earlier Ipsogen) Business Overview
11.12.3 QIAGEN Marseille (Earlier Ipsogen) Cancer Test Introduction
11.12.4 QIAGEN Marseille (Earlier Ipsogen) Revenue in Cancer Test Business (2016-2021)
11.12.5 QIAGEN Marseille (Earlier Ipsogen) Recent Development
11.13 Myriad Genetics
11.13.1 Myriad Genetics Company Details
11.13.2 Myriad Genetics Business Overview
11.13.3 Myriad Genetics Cancer Test Introduction
11.13.4 Myriad Genetics Revenue in Cancer Test Business (2016-2021)
11.13.5 Myriad Genetics Recent Development
11.14 Panacea Pharmaceuticals
11.14.1 Panacea Pharmaceuticals Company Details
11.14.2 Panacea Pharmaceuticals Business Overview
11.14.3 Panacea Pharmaceuticals Cancer Test Introduction
11.14.4 Panacea Pharmaceuticals Revenue in Cancer Test Business (2016-2021)
11.14.5 Panacea Pharmaceuticals Recent Development
11.15 Qiagen
11.15.1 Qiagen Company Details
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Cancer Test Introduction
11.15.4 Qiagen Revenue in Cancer Test Business (2016-2021)
11.15.5 Qiagen Recent Development
11.16 Siemens Heathcare Diagnostics
11.16.1 Siemens Heathcare Diagnostics Company Details
11.16.2 Siemens Heathcare Diagnostics Business Overview
11.16.3 Siemens Heathcare Diagnostics Cancer Test Introduction
11.16.4 Siemens Heathcare Diagnostics Revenue in Cancer Test Business (2016-2021)
11.16.5 Siemens Heathcare Diagnostics Recent Development
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Cancer Test Introduction
11.17.4 Roche Revenue in Cancer Test Business (2016-2021)
11.17.5 Roche Recent Development
11.18 Roche(Ventana Medical Systems)
11.18.1 Roche(Ventana Medical Systems) Company Details
11.18.2 Roche(Ventana Medical Systems) Business Overview
11.18.3 Roche(Ventana Medical Systems) Cancer Test Introduction
11.18.4 Roche(Ventana Medical Systems) Revenue in Cancer Test Business (2016-2021)
11.18.5 Roche(Ventana Medical Systems) Recent Development
11.18 Trovagene
.1 Trovagene Company Details
.2 Trovagene Business Overview
.3 Trovagene Cancer Test Introduction
.4 Trovagene Revenue in Cancer Test Business (2016-2021)
.5 Trovagene Recent Development
11.20 Vermillion
11.20.1 Vermillion Company Details
11.20.2 Vermillion Business Overview
11.20.3 Vermillion Cancer Test Introduction
11.20.4 Vermillion Revenue in Cancer Test Business (2016-2021)
11.20.5 Vermillion Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Laboratory Tests
Table 3. Key Players of Genetic Tests
Table 4. Key Players of Imaging
Table 5. Key Players of Endoscopy
Table 6. Global Cancer Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Test Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cancer Test Market Share by Regions (2016-2021)
Table 10. Global Cancer Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cancer Test Market Share by Regions (2022-2027)
Table 12. Cancer Test Market Trends
Table 13. Cancer Test Market Drivers
Table 14. Cancer Test Market Challenges
Table 15. Cancer Test Market Restraints
Table 16. Global Cancer Test Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cancer Test Market Share by Players (2016-2021)
Table 18. Global Top Cancer Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Test as of 2020)
Table 19. Ranking of Global Top Cancer Test Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cancer Test Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Test Product Solution and Service
Table 23. Date of Enter into Cancer Test Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cancer Test Revenue Market Share by Type (2016-2021)
Table 27. Global Cancer Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cancer Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cancer Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cancer Test Revenue Market Share by Application (2016-2021)
Table 31. Global Cancer Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cancer Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cancer Test Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cancer Test Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cancer Test Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cancer Test Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cancer Test Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cancer Test Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cancer Test Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cancer Test Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cancer Test Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cancer Test Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Test Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Test Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer Test Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer Test Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cancer Test Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cancer Test Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Test Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cancer Test Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cancer Test Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cancer Test Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Test Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Test Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Test Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer Test Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer Test Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cancer Test Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Cancer Test Product
Table 66. Abbott Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Radient Pharmaceuticals Company Details
Table 69. Radient Pharmaceuticals Business Overview
Table 70. Radient Pharmaceuticals Cancer Test Product
Table 71. Radient Pharmaceuticals Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 72. Radient Pharmaceuticals Recent Development
Table 73. BD Diagnostics Company Details
Table 74. BD Diagnostics Business Overview
Table 75. BD Diagnostics Cancer Test Product
Table 76. BD Diagnostics Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 77. BD Diagnostics Recent Development
Table 78. Beckman Coulter Company Details
Table 79. Beckman Coulter Business Overview
Table 80. Beckman Coulter Cancer Test Product
Table 81. Beckman Coulter Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 82. Beckman Coulter Recent Development
Table 83. BioCurex Company Details
Table 84. BioCurex Business Overview
Table 85. BioCurex Cancer Test Product
Table 86. BioCurex Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 87. BioCurex Recent Development
Table 88. bioMerieux Company Details
Table 89. bioMerieux Business Overview
Table 90. bioMerieux Cancer Test Product
Table 91. bioMerieux Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 92. bioMerieux Recent Development
Table 93. Cepheid Company Details
Table 94. Cepheid Business Overview
Table 95. Cepheid Cancer Test Product
Table 96. Cepheid Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 97. Cepheid Recent Development
Table 98. CytoCore Company Details
Table 99. CytoCore Business Overview
Table 100. CytoCore Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 101. CytoCore Recent Development
Table 102. DiagnoCure Company Details
Table 103. DiagnoCure Business Overview
Table 104. DiagnoCure Cancer Test Product
Table 105. DiagnoCure Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 106. DiagnoCure Recent Development
Table 107. Gen-Probe Company Details
Table 108. Gen-Probe Business Overview
Table 109. Gen-Probe Cancer Test Product
Table 110. Gen-Probe Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 111. Gen-Probe Recent Development
Table 112. Genomic Health Company Details
Table 113. Genomic Health Business Overview
Table 114. Genomic Health Cancer Test Product
Table 115. Genomic Health Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 116. Genomic Health Recent Development
Table 117. QIAGEN Marseille (Earlier Ipsogen) Company Details
Table 118. QIAGEN Marseille (Earlier Ipsogen) Business Overview
Table 119. QIAGEN Marseille (Earlier Ipsogen) Cancer Test Product
Table 120. QIAGEN Marseille (Earlier Ipsogen) Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 121. QIAGEN Marseille (Earlier Ipsogen) Recent Development
Table 122. Myriad Genetics Company Details
Table 123. Myriad Genetics Business Overview
Table 124. Myriad Genetics Cancer Test Product
Table 125. Myriad Genetics Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 126. Myriad Genetics Recent Development
Table 127. Panacea Pharmaceuticals Company Details
Table 128. Panacea Pharmaceuticals Business Overview
Table 129. Panacea Pharmaceuticals Cancer Test Product
Table 130. Panacea Pharmaceuticals Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 131. Panacea Pharmaceuticals Recent Development
Table 132. Qiagen Company Details
Table 133. Qiagen Business Overview
Table 134. Qiagen Cancer Test Product
Table 135. Qiagen Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 136. Qiagen Recent Development
Table 137. Siemens Heathcare Diagnostics Company Details
Table 138. Siemens Heathcare Diagnostics Business Overview
Table 139. Siemens Heathcare Diagnostics Cancer Test Product
Table 140. Siemens Heathcare Diagnostics Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 141. Siemens Heathcare Diagnostics Recent Development
Table 142. Roche Company Details
Table 143. Roche Business Overview
Table 144. Roche Cancer Test Product
Table 145. Roche Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 146. Roche Recent Development
Table 147. Roche(Ventana Medical Systems) Company Details
Table 148. Roche(Ventana Medical Systems) Business Overview
Table 149. Roche(Ventana Medical Systems) Cancer Test Product
Table 150. Roche(Ventana Medical Systems) Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 151. Roche(Ventana Medical Systems) Recent Development
Table 152. Trovagene Company Details
Table 153. Trovagene Business Overview
Table 154. Trovagene Cancer Test Product
Table 155. Trovagene Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 156. Trovagene Recent Development
Table 157. Vermillion Company Details
Table 158. Vermillion Business Overview
Table 159. Vermillion Cancer Test Product
Table 160. Vermillion Revenue in Cancer Test Business (2016-2021) & (US$ Million)
Table 161. Vermillion Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Test Market Share by Type: 2020 VS 2027
Figure 2. Laboratory Tests Features
Figure 3. Genetic Tests Features
Figure 4. Imaging Features
Figure 5. Endoscopy Features
Figure 6. Global Cancer Test Market Share by Application: 2020 VS 2027
Figure 7. Bladder Cancer Test Case Studies
Figure 8. Breast Cancer Test Case Studies
Figure 9. Cervical Cancer Test Case Studies
Figure 10. Colorectal (Colon) Cancer Test Case Studies
Figure 11. Ovarian Cancer Test Case Studies
Figure 12. Prostate Cancer Test Case Studies
Figure 13. Liver Cancer Test Case Studies
Figure 14. Flow Cytometry Case Studies
Figure 15. Other Organ Specific Cancer Test Case Studies
Figure 16. Cancer Test Report Years Considered
Figure 17. Global Cancer Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Cancer Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Cancer Test Market Share by Regions: 2020 VS 2027
Figure 20. Global Cancer Test Market Share by Regions (2022-2027)
Figure 21. Global Cancer Test Market Share by Players in 2020
Figure 22. Global Top Cancer Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Test as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Cancer Test Revenue in 2020
Figure 24. Global Cancer Test Revenue Market Share by Type (2016-2021)
Figure 25. Global Cancer Test Revenue Market Share by Type (2022-2027)
Figure 26. North America Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Cancer Test Market Share by Type (2016-2027)
Figure 28. North America Cancer Test Market Share by Application (2016-2027)
Figure 29. North America Cancer Test Market Share by Country (2016-2027)
Figure 30. United States Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Cancer Test Market Share by Type (2016-2027)
Figure 34. Europe Cancer Test Market Share by Application (2016-2027)
Figure 35. Europe Cancer Test Market Share by Country (2016-2027)
Figure 36. Germany Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Cancer Test Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Cancer Test Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Cancer Test Market Share by Region (2016-2027)
Figure 46. China Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Cancer Test Market Share by Type (2016-2027)
Figure 54. Latin America Cancer Test Market Share by Application (2016-2027)
Figure 55. Latin America Cancer Test Market Share by Country (2016-2027)
Figure 56. Mexico Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Cancer Test Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Cancer Test Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Cancer Test Market Share by Country (2016-2027)
Figure 62. Turkey Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Cancer Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Abbott Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 66. Radient Pharmaceuticals Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 67. BD Diagnostics Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 68. Beckman Coulter Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 69. BioCurex Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 70. bioMerieux Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 71. Cepheid Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 72. CytoCore Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 73. DiagnoCure Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 74. Gen-Probe Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 75. Genomic Health Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 76. QIAGEN Marseille (Earlier Ipsogen) Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 77. Myriad Genetics Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 78. Panacea Pharmaceuticals Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 79. Qiagen Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 80. Siemens Heathcare Diagnostics Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 81. Roche Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 82. Roche(Ventana Medical Systems) Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 83. Trovagene Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 84. Vermillion Revenue Growth Rate in Cancer Test Business (2016-2021)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
世界の子宮頸がん検査市場規模・現状・予測（2021年-2027年） Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA …- 世界の子宮頸がん検査市場規模・現状・予測（2021年-2027年） Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA …
- 世界のがん検査市場 2021：企業別、地域別、種類・用途別 The Cancer Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
- 世界の子宮頸がん検査市場 2021：企業別、地域別、種類・用途別 The Cervical Cancer Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の腫瘍バイオマーカー検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Biomarker Test Market The global Tumor Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…